Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (466)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
20
2023
355
2.990
 Why?
Anus Neoplasms
10
2023
24
2.170
 Why?
Stroke
7
2024
485
1.840
 Why?
Acquired Immunodeficiency Syndrome
11
2022
52
1.630
 Why?
Prostatic Hyperplasia
10
2015
38
1.480
 Why?
Brain
9
2024
1313
1.420
 Why?
Parkinson Disease
2
2023
145
1.290
 Why?
Randomized Controlled Trials as Topic
8
2024
556
1.250
 Why?
Chlamydia Infections
8
2017
75
1.230
 Why?
Sarcoma, Kaposi
12
2022
75
1.070
 Why?
Papillomavirus Infections
5
2022
168
1.040
 Why?
Chlamydia trachomatis
6
2017
29
1.030
 Why?
Lymphoma, AIDS-Related
10
2020
16
1.000
 Why?
Plant Extracts
5
2013
166
0.930
 Why?
Brain Ischemia
2
2023
159
0.920
 Why?
Mesenchymal Stem Cell Transplantation
1
2024
17
0.910
 Why?
Humans
102
2025
50389
0.880
 Why?
Serenoa
5
2013
7
0.880
 Why?
Rural Population
4
2023
552
0.810
 Why?
Phytotherapy
3
2012
42
0.810
 Why?
Umbilical Cord
2
2020
35
0.800
 Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.730
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1003
0.730
 Why?
Middle Aged
50
2021
12460
0.720
 Why?
Research Design
5
2022
344
0.700
 Why?
Male
61
2024
25718
0.670
 Why?
Rats
9
2024
3287
0.670
 Why?
Neonatal Abstinence Syndrome
3
2024
25
0.670
 Why?
Fetal Blood
2
2019
70
0.660
 Why?
Infarction, Middle Cerebral Artery
4
2024
40
0.640
 Why?
Adult
48
2022
13568
0.640
 Why?
Inflammation
3
2021
608
0.630
 Why?
Patient Participation
1
2018
68
0.590
 Why?
Vaginosis, Bacterial
2
2015
8
0.560
 Why?
Neoplasms
3
2023
1237
0.530
 Why?
Decision Making
1
2018
273
0.520
 Why?
Mammography
1
2016
100
0.520
 Why?
Female
48
2024
26981
0.500
 Why?
Antineoplastic Agents
9
2023
1178
0.500
 Why?
Aged
28
2020
9590
0.490
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
47
0.490
 Why?
Animals
16
2025
13173
0.470
 Why?
Population Density
1
2014
15
0.470
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.470
 Why?
AIDS-Related Opportunistic Infections
5
2016
40
0.470
 Why?
Stem Cell Transplantation
4
2025
179
0.460
 Why?
Carcinoma in Situ
3
2013
73
0.450
 Why?
Rats, Sprague-Dawley
7
2024
1582
0.450
 Why?
Cytokines
5
2023
606
0.450
 Why?
Anti-Bacterial Agents
5
2020
745
0.440
 Why?
Uterine Cervicitis
1
2013
3
0.430
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.420
 Why?
Urethritis
2
2012
5
0.420
 Why?
Finasteride
4
2015
4
0.410
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
104
0.410
 Why?
Guideline Adherence
1
2013
133
0.400
 Why?
Research Subjects
1
2013
50
0.400
 Why?
Subarachnoid Hemorrhage
1
2012
61
0.390
 Why?
Breast Neoplasms
3
2017
1189
0.390
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
152
0.390
 Why?
Patient Dropouts
1
2012
51
0.390
 Why?
Urologic Diseases
1
2011
10
0.380
 Why?
HIV-1
6
2020
53
0.370
 Why?
Analgesics, Opioid
4
2024
568
0.370
 Why?
Lung Neoplasms
2
2013
600
0.360
 Why?
Disease Models, Animal
5
2024
1419
0.350
 Why?
Stem Cells
3
2025
171
0.350
 Why?
United States
10
2023
4913
0.340
 Why?
Patient Selection
1
2011
257
0.330
 Why?
Young Adult
16
2018
4064
0.330
 Why?
Asthma
2
2024
282
0.330
 Why?
Quality of Life
6
2024
844
0.330
 Why?
Lymphedema
2
2022
43
0.330
 Why?
HIV Seropositivity
3
2021
27
0.320
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.320
 Why?
Intestinal Mucosa
2
2021
216
0.320
 Why?
Polymorphism, Single Nucleotide
3
2017
482
0.310
 Why?
Gonorrhea
2
2020
9
0.300
 Why?
Azithromycin
4
2020
25
0.300
 Why?
Risk Factors
8
2022
3692
0.280
 Why?
Th1 Cells
2
2017
53
0.280
 Why?
Vascular Endothelial Growth Factor A
4
2017
183
0.270
 Why?
Treatment Outcome
17
2020
5230
0.260
 Why?
Mycoplasma genitalium
2
2018
2
0.260
 Why?
Doxazosin
3
2015
3
0.260
 Why?
Mycoplasma Infections
2
2018
7
0.260
 Why?
Anti-Infective Agents
2
2020
95
0.250
 Why?
Cyclophosphamide
9
2021
164
0.250
 Why?
Prospective Studies
11
2022
2414
0.250
 Why?
Doxycycline
3
2015
33
0.250
 Why?
Cancer Vaccines
1
2006
78
0.250
 Why?
Vincristine
8
2021
85
0.240
 Why?
Multicenter Studies as Topic
4
2024
88
0.240
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
555
0.240
 Why?
Circadian Rhythm
1
2025
89
0.240
 Why?
Adolescent
13
2022
6475
0.230
 Why?
Air Filters
1
2024
1
0.230
 Why?
Double-Blind Method
4
2013
682
0.230
 Why?
Thymus Gland
2
2021
42
0.230
 Why?
Air Pollution, Indoor
1
2024
25
0.230
 Why?
CD4 Lymphocyte Count
7
2020
32
0.230
 Why?
Bronchiolitis
1
2024
27
0.230
 Why?
Prevalence
6
2021
970
0.220
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.220
 Why?
Hyperbaric Oxygenation
1
2023
14
0.220
 Why?
Homosexuality, Male
3
2022
52
0.220
 Why?
Substantia Nigra
1
2023
14
0.220
 Why?
Cell Differentiation
3
2025
651
0.220
 Why?
alpha-Synuclein
1
2023
8
0.220
 Why?
Doxorubicin
8
2021
234
0.220
 Why?
Transplantation Conditioning
2
2018
82
0.210
 Why?
Nervous System Diseases
1
2024
88
0.210
 Why?
Tumor Necrosis Factor-alpha
2
2017
388
0.210
 Why?
Informatics
1
2023
8
0.210
 Why?
Prednisone
7
2021
101
0.210
 Why?
Herpesvirus 8, Human
5
2020
95
0.210
 Why?
Cross-Sectional Studies
3
2021
1590
0.210
 Why?
Follow-Up Studies
8
2019
2219
0.210
 Why?
Astrocytes
1
2024
145
0.200
 Why?
Brachytherapy
1
2022
46
0.200
 Why?
Child
8
2024
6877
0.200
 Why?
Watchful Waiting
1
2022
27
0.200
 Why?
Medical Records
1
2022
86
0.200
 Why?
Absorptiometry, Photon
1
2003
155
0.200
 Why?
Feasibility Studies
2
2021
386
0.200
 Why?
Substance Withdrawal Syndrome
1
2023
167
0.200
 Why?
Genome-Wide Association Study
3
2018
163
0.200
 Why?
Vitamin D Deficiency
1
2022
44
0.200
 Why?
Brain Injuries
1
2023
159
0.200
 Why?
Viral Load
6
2020
76
0.200
 Why?
Vaccines
1
2022
49
0.190
 Why?
Case-Control Studies
3
2014
1148
0.190
 Why?
Precancerous Conditions
1
2022
83
0.190
 Why?
Clinical Trials as Topic
5
2020
465
0.190
 Why?
Mouth Diseases
1
2021
5
0.190
 Why?
Lymphocyte Activation
3
2017
172
0.190
 Why?
Vaccination
3
2022
275
0.190
 Why?
Papillomaviridae
2
2016
103
0.190
 Why?
Mass Screening
2
2015
348
0.190
 Why?
Neoplasm Staging
4
2022
750
0.180
 Why?
Pluripotent Stem Cells
1
2021
6
0.180
 Why?
Physical Conditioning, Animal
1
2021
54
0.180
 Why?
Primary Health Care
2
2022
364
0.180
 Why?
T-Lymphocyte Subsets
2
2017
38
0.180
 Why?
Drug Therapy, Combination
5
2015
383
0.180
 Why?
Papillomavirus Vaccines
2
2013
67
0.180
 Why?
Vagina
2
2018
45
0.180
 Why?
Etoposide
5
2021
71
0.180
 Why?
Anti-HIV Agents
3
2020
42
0.180
 Why?
Spleen
1
2021
170
0.180
 Why?
Enzyme Inhibitors
2
2016
378
0.180
 Why?
Cross-Over Studies
1
2021
224
0.180
 Why?
Genes, myc
1
2020
40
0.170
 Why?
Gene Frequency
2
2017
95
0.170
 Why?
Overweight
1
2022
217
0.170
 Why?
Transplantation, Autologous
3
2018
464
0.170
 Why?
Aged, 80 and over
5
2013
3180
0.170
 Why?
Uterine Cervical Neoplasms
1
2022
278
0.170
 Why?
Dihydroxyphenylalanine
1
2019
5
0.170
 Why?
Dopaminergic Neurons
1
2019
18
0.160
 Why?
Empathy
1
2019
46
0.160
 Why?
Ablation Techniques
1
2019
22
0.160
 Why?
Infant, Newborn
5
2024
2780
0.160
 Why?
Social Environment
1
2019
79
0.160
 Why?
Altruism
1
2018
12
0.160
 Why?
Sodium, Dietary
1
2019
23
0.160
 Why?
Mitochondria
2
2020
398
0.160
 Why?
Central Nervous System Diseases
1
2019
26
0.160
 Why?
Asymptomatic Infections
1
2018
5
0.150
 Why?
Antiviral Agents
2
2013
168
0.150
 Why?
Dopamine
1
2019
171
0.150
 Why?
Sexually Transmitted Diseases
1
2018
36
0.150
 Why?
Acoustic Stimulation
1
2018
99
0.150
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
234
0.150
 Why?
Energy Metabolism
1
2020
284
0.150
 Why?
Protein Kinase Inhibitors
2
2023
205
0.150
 Why?
Hyperthermia, Induced
1
2019
116
0.150
 Why?
Chlamydia
1
2017
8
0.150
 Why?
Mucous Membrane
1
2017
28
0.150
 Why?
Blood Cells
1
2017
43
0.140
 Why?
Biopsy
2
2022
592
0.140
 Why?
Genetic Predisposition to Disease
2
2018
509
0.140
 Why?
Pilot Projects
3
2019
704
0.140
 Why?
Clostridium Infections
1
2018
53
0.140
 Why?
DNA, Circular
1
2017
18
0.140
 Why?
Antibodies, Bacterial
1
2017
28
0.140
 Why?
Clonal Evolution
1
2017
56
0.140
 Why?
Immunoglobulins
1
2017
80
0.140
 Why?
Immunoglobulin G
1
2017
185
0.130
 Why?
Anus Diseases
1
2016
2
0.130
 Why?
Sentinel Lymph Node Biopsy
1
2017
118
0.130
 Why?
Telemedicine
1
2022
468
0.130
 Why?
Mannitol
1
2016
15
0.130
 Why?
Lymph Node Excision
1
2017
138
0.130
 Why?
Thiazoles
1
2016
53
0.130
 Why?
Guidelines as Topic
1
2016
110
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.130
 Why?
Diagnostic Self Evaluation
1
2015
14
0.130
 Why?
Comorbidity
2
2018
617
0.130
 Why?
Blood-Brain Barrier
1
2016
48
0.130
 Why?
Anal Canal
3
2023
21
0.130
 Why?
CD4-Positive T-Lymphocytes
1
2017
157
0.130
 Why?
Dose-Response Relationship, Drug
4
2013
1356
0.130
 Why?
Educational Status
1
2016
227
0.120
 Why?
T-Lymphocytes
1
2017
331
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
Burkitt Lymphoma
1
2015
26
0.120
 Why?
Imidazoles
1
2016
128
0.120
 Why?
Drug Administration Schedule
5
2020
369
0.120
 Why?
Lymph Nodes
1
2017
258
0.120
 Why?
Menarche
1
2014
7
0.120
 Why?
Stomatitis
1
2014
16
0.120
 Why?
Data Collection
3
2023
283
0.120
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.120
 Why?
Obesity
3
2022
1125
0.120
 Why?
Immunophenotyping
2
2017
111
0.120
 Why?
Disease-Free Survival
5
2016
450
0.110
 Why?
Hypogonadism
1
2013
10
0.110
 Why?
Benzamides
1
2013
51
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
325
0.110
 Why?
Incidence
4
2018
1017
0.110
 Why?
Health Surveys
1
2014
236
0.110
 Why?
SEER Program
1
2013
93
0.110
 Why?
Urban Population
1
2014
152
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2018
377
0.110
 Why?
Regenerative Medicine
2
2025
10
0.110
 Why?
Organophosphonates
1
2013
7
0.110
 Why?
Testosterone
1
2013
137
0.110
 Why?
Heart Failure
1
2019
526
0.110
 Why?
Stress, Psychological
2
2019
261
0.110
 Why?
Perineum
1
2013
24
0.110
 Why?
DNA, Viral
3
2020
133
0.110
 Why?
Placebos
1
2013
84
0.110
 Why?
Cytosine
1
2013
30
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
tau Proteins
1
2012
22
0.100
 Why?
Piperazines
1
2013
118
0.100
 Why?
Prostate
2
2015
117
0.100
 Why?
HIV
3
2023
25
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
60
0.100
 Why?
Sleep
2
2024
180
0.100
 Why?
Pyrimidines
1
2013
193
0.100
 Why?
Vulvar Neoplasms
1
2013
58
0.100
 Why?
Time Factors
5
2023
2934
0.100
 Why?
Medicare
1
2013
245
0.100
 Why?
Androgen Antagonists
1
2011
11
0.100
 Why?
Urination Disorders
1
2011
23
0.100
 Why?
Sirolimus
1
2012
62
0.100
 Why?
Antibiotics, Antineoplastic
1
2012
77
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
123
0.090
 Why?
Kenya
2
2022
10
0.090
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Arkansas
1
2016
1991
0.090
 Why?
Practice Guidelines as Topic
1
2013
460
0.090
 Why?
Social Class
1
2011
96
0.090
 Why?
Prognosis
5
2017
1979
0.090
 Why?
Multivariate Analysis
1
2012
583
0.090
 Why?
Chronic Disease
1
2012
570
0.090
 Why?
Methotrexate
2
2015
73
0.090
 Why?
Piperidines
1
2011
96
0.090
 Why?
Plant Bark
1
2009
6
0.090
 Why?
Multiple Myeloma
2
2014
2949
0.080
 Why?
Valproic Acid
1
2009
32
0.080
 Why?
Colorectal Neoplasms
1
2013
256
0.080
 Why?
Ki-67 Antigen
1
2009
57
0.080
 Why?
Socioeconomic Factors
1
2012
590
0.080
 Why?
India
2
2021
52
0.080
 Why?
Logistic Models
1
2012
900
0.080
 Why?
Fruit
1
2009
114
0.080
 Why?
Tetracyclines
2
2006
9
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
634
0.080
 Why?
Cisplatin
2
2022
275
0.080
 Why?
Antiretroviral Therapy, Highly Active
3
2015
33
0.070
 Why?
Survival Analysis
3
2017
671
0.070
 Why?
Glomerulonephritis, IGA
1
2007
5
0.070
 Why?
Galactose
1
2007
28
0.070
 Why?
Immunoglobulin A
1
2007
45
0.070
 Why?
Glioblastoma
1
2009
92
0.070
 Why?
Adaptive Immunity
2
2017
31
0.070
 Why?
Sexual Partners
2
2018
31
0.070
 Why?
Disease Progression
4
2013
823
0.070
 Why?
Regression Analysis
2
2018
396
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Lymphocyte Count
1
2006
20
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
31
0.070
 Why?
Sexual Behavior
2
2018
115
0.070
 Why?
Viral Vaccines
1
2006
12
0.070
 Why?
HIV Protease Inhibitors
1
2006
2
0.070
 Why?
Immunohistochemistry
3
2017
975
0.070
 Why?
Interferon-alpha
1
2006
48
0.060
 Why?
Infant
2
2024
3601
0.060
 Why?
Nephrosis, Lipoid
1
2005
5
0.060
 Why?
Arterioles
1
2005
33
0.060
 Why?
Brain Neoplasms
1
2009
288
0.060
 Why?
Body Mass Index
2
2022
669
0.060
 Why?
Severity of Illness Index
2
2023
963
0.060
 Why?
Recombinant Fusion Proteins
1
2006
186
0.060
 Why?
Circadian Clocks
1
2025
1
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
87
0.060
 Why?
Administration, Oral
4
2013
432
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Administration, Intranasal
1
2024
30
0.060
 Why?
Phenotype
2
2017
736
0.060
 Why?
Leucovorin
1
2004
21
0.060
 Why?
Purines
1
2004
38
0.060
 Why?
Genotype
2
2017
539
0.060
 Why?
Neutropenia
2
2020
114
0.060
 Why?
Confidence Intervals
2
2015
154
0.060
 Why?
Dust
1
2024
22
0.060
 Why?
Particulate Matter
1
2024
53
0.060
 Why?
Carbon
1
2024
55
0.060
 Why?
Arthritis, Rheumatoid
1
2004
105
0.060
 Why?
Folic Acid
1
2004
139
0.060
 Why?
Cytochrome P-450 CYP3A
1
2023
77
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
5
0.050
 Why?
Hip
1
2003
25
0.050
 Why?
Drug Delivery Systems
1
2024
143
0.050
 Why?
Bacterial Proteins
1
2006
371
0.050
 Why?
Narcotics
1
2023
107
0.050
 Why?
Quality Control
1
2003
95
0.050
 Why?
Sample Size
1
2022
37
0.050
 Why?
Eating
1
2023
158
0.050
 Why?
Breast Feeding
1
2024
189
0.050
 Why?
Vitamins
1
2022
63
0.050
 Why?
Femur
1
2003
132
0.050
 Why?
Spine
1
2003
91
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Radiotherapy Dosage
1
2022
247
0.050
 Why?
Vitamin D
1
2022
88
0.050
 Why?
Tretinoin
1
2002
53
0.050
 Why?
Leg
1
2022
123
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
35
0.050
 Why?
Antibodies, Monoclonal
1
2005
462
0.050
 Why?
Museums
1
2021
2
0.050
 Why?
Alprostadil
1
2021
10
0.050
 Why?
Length of Stay
1
2024
627
0.050
 Why?
Kidney
1
2005
686
0.050
 Why?
Oxygen
1
2023
321
0.050
 Why?
Zimbabwe
1
2020
2
0.040
 Why?
Malawi
1
2020
10
0.040
 Why?
Uganda
1
2020
36
0.040
 Why?
Wharton Jelly
1
2020
1
0.040
 Why?
Software
1
2003
274
0.040
 Why?
Herpesvirus 4, Human
1
2020
39
0.040
 Why?
Body Composition
1
2003
326
0.040
 Why?
Cell Shape
1
2020
20
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Herpesviridae Infections
1
2020
53
0.040
 Why?
Ceftriaxone
1
2020
26
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
57
0.040
 Why?
B-Lymphocytes
1
2021
175
0.040
 Why?
Drug Resistance, Bacterial
1
2020
72
0.040
 Why?
Thrombocytopenia
1
2020
84
0.040
 Why?
Cohort Studies
2
2018
1426
0.040
 Why?
Remission Induction
2
2012
206
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Interleukin-6
2
2016
266
0.040
 Why?
Kaplan-Meier Estimate
1
2020
466
0.040
 Why?
Microbial Sensitivity Tests
1
2020
271
0.040
 Why?
Cell Survival
1
2020
590
0.040
 Why?
Masks
1
2018
30
0.040
 Why?
Statistics, Nonparametric
2
2013
193
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Models, Animal
1
2019
228
0.040
 Why?
Coinfection
1
2018
41
0.040
 Why?
Neurodegenerative Diseases
1
2019
75
0.040
 Why?
Bone Marrow
1
2019
356
0.040
 Why?
Pandemics
1
2022
564
0.040
 Why?
Neurogenesis
1
2017
24
0.040
 Why?
Cell Separation
1
2017
89
0.040
 Why?
Cytological Techniques
1
2017
14
0.040
 Why?
Angiopoietin-2
1
2017
15
0.030
 Why?
Interleukin-2
1
2017
70
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
91
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.030
 Why?
Staining and Labeling
1
2017
97
0.030
 Why?
Fluorouracil
1
2016
56
0.030
 Why?
Gene Rearrangement
1
2017
74
0.030
 Why?
Biopsy, Needle
1
2017
182
0.030
 Why?
Odds Ratio
1
2018
551
0.030
 Why?
Neuroprotective Agents
1
2017
100
0.030
 Why?
Membrane Glycoproteins
1
2017
244
0.030
 Why?
Interferon-gamma
1
2017
176
0.030
 Why?
Chemoradiotherapy
1
2016
43
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
5
0.030
 Why?
Mastectomy
1
2017
142
0.030
 Why?
Directly Observed Therapy
1
2015
7
0.030
 Why?
Urine
1
2015
23
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
17
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Neovascularization, Pathologic
1
2017
153
0.030
 Why?
RNA, Viral
2
2009
123
0.030
 Why?
Neoadjuvant Therapy
1
2017
119
0.030
 Why?
Treatment Failure
1
2015
115
0.030
 Why?
Prisons
1
2015
38
0.030
 Why?
Ifosfamide
1
2015
8
0.030
 Why?
Cytarabine
1
2015
40
0.030
 Why?
Flow Cytometry
1
2017
475
0.030
 Why?
Induction Chemotherapy
1
2014
60
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
58
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Depression
1
2019
572
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
36
0.030
 Why?
Melphalan
1
2014
173
0.030
 Why?
Statistics as Topic
1
2013
87
0.030
 Why?
Cancer Care Facilities
1
2013
19
0.030
 Why?
Time
1
2013
28
0.030
 Why?
Administration, Cutaneous
1
2013
53
0.030
 Why?
Infusions, Intravenous
1
2013
213
0.030
 Why?
Gene Expression Regulation
1
2017
964
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
121
0.030
 Why?
Demography
1
2013
93
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
60
0.030
 Why?
Antitrichomonal Agents
1
2012
1
0.030
 Why?
Risk Assessment
1
2017
1258
0.030
 Why?
Combined Modality Therapy
1
2014
641
0.030
 Why?
Reference Values
1
2013
312
0.030
 Why?
Polyethylene Glycols
1
2012
86
0.030
 Why?
Medical Oncology
1
2013
96
0.020
 Why?
Antigens, Viral
1
2012
43
0.020
 Why?
Administration, Topical
1
2011
57
0.020
 Why?
Single-Blind Method
1
2011
114
0.020
 Why?
Sex Factors
1
2013
702
0.020
 Why?
Neoplasm Proteins
1
2013
321
0.020
 Why?
Organ Size
1
2011
223
0.020
 Why?
Antibodies, Viral
1
2010
92
0.020
 Why?
Retrospective Studies
1
2022
6223
0.020
 Why?
Survival Rate
1
2012
915
0.020
 Why?
Anti-Retroviral Agents
1
2008
13
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
322
0.020
 Why?
Psychometrics
1
2009
228
0.020
 Why?
Lectins
1
2007
14
0.020
 Why?
Busulfan
1
2008
19
0.020
 Why?
Mutation
1
2013
1292
0.020
 Why?
Glycosylation
1
2007
102
0.020
 Why?
Mice
1
2017
5688
0.020
 Why?
Ultrasonography
1
2008
438
0.020
 Why?
Maximum Tolerated Dose
1
2006
40
0.020
 Why?
Injections, Subcutaneous
1
2006
51
0.020
 Why?
Hypertension, Renal
1
2005
22
0.020
 Why?
Cell Proliferation
1
2009
989
0.020
 Why?
Fatigue
1
2006
118
0.020
 Why?
Pyridoxine
1
2004
4
0.010
 Why?
Ribonucleotides
1
2004
5
0.010
 Why?
Vitamin B 12
1
2004
29
0.010
 Why?
Recombinant Proteins
1
2006
482
0.010
 Why?
Erythrocytes
1
2004
83
0.010
 Why?
Adenosine
1
2004
70
0.010
 Why?
Homocysteine
1
2004
127
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
59
0.010
 Why?
Safety
1
2002
77
0.010
 Why?
Child, Preschool
1
2005
3908
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (466) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department